Norocillin

Dosage Form: FOR ANIMAL USE ONLY
Norocillin

Injectable Antibiotic

NADA 065-010, APPROVED BY FDA

For use in Cattle, Sheep, Swine and Horses.

PENICILLIN G PROCAINE INJECTABLE SUSPENSION U.S.P.

READ ENTIRE BROCHURE CAREFULLY BEFORE USING THIS PRODUCT

Description:

Norocillin is a suspension of penicillin G procaine in 100, 250, and 500 mL multiple dose vials. Each mL is designed to provide 300,000 units of penicillin G as procaine in a stable suspension. Penicillin G procaine is an antibacterial agent which has activity against a variety of pathogenic organisms, mainly in the Gram-positive category.

Indications:

Norocillin is indicated for treatment of bacterial pneumonia (shipping fever) caused by Pasteurella multocida in cattle and sheep, erysipelas caused by Erysipelothrix rhusiopathiae in swine, and strangles caused by Streptococcus equi in horses.

Directions for Use:

A thoroughly cleaned, sterile needle and syringe should be used for each injection (needles and syringes may be sterilized in boiling water for 15 minutes).Before withdrawing the solution from the bottle, disinfect the rubber cap top with 70% alcohol. The injection site should be similarly disinfected with alcohol. Needles of 16 to 18 gauge and 1 to 1.5 inches long are adequate for intramuscular injections.

In livestock intramuscular injections should be made by directing the needle of suitable gauge and length into the fleshy part of a thick muscle, such as rump, hip, or thigh region; avoid blood vessels and major nerves. Before injecting the solution, pull back gently on the plunger. If blood appears in the syringe, a blood vessel has been entered; withdraw the needle and select a different site.

Dosage:

Norocillin is administered by the intramuscular route. The product is ready for injection after warming the vial to room temperature and shaking to ensure a uniform suspension.

The daily dose of penicillin is 3,000 units per pound of body weight (1 mL per 100 lbs body weight). Continue daily treatment until recovery is apparent and for at least one day after symptoms disappear, usually in two to three days.

Treatment should not exceed four consecutive days.

No more than 10 mL should be injected at any one site. Rotate injection sites for each succeeding treatment.

Care of Sick Animals:

The use of antibiotics in the management of diseases is based on an accurate diagnosis and an adequate course of treatment. When properly used in the treatment of diseases caused by penicillin-susceptible organisms, most animals treated with Norocillin show a noticeable improvement within 24 to 48 hours. If improvement does not occur within this period of time, the diagnosis and course of treatment should be re-evaluated. It is recommended that the diagnosis and treatment of animal diseases be carried out by a veterinarian.

Since many diseases look alike but require different types of treatment, the use of professional veterinary and laboratory services can reduce treatment time, costs and needless losses. Good housing, sanitation and nutrition are important in the maintenance of healthy animals and are essential in the treatment of disease.

Residue Warnings:

Exceeding the daily dosage of 3,000 units per pound of body weight, administering for more than four consecutive days, or exceeding the maximum injection site volume per injection site may result in antibiotic residues beyond the withdrawal time. Milk taken from treated dairy animals within 48 hours after the last treatment must not be used for food. Discontinue use of this drug for the following time period before treated animals are slaughtered for food:

Cattle – 14 days, Sheep – 9 days, Swine – 7 days.

A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Warning:

Do not use in horses intended for human consumption. Not for use in humans. Keep out of reach of children.

Precautions:

Intramuscular injection in cattle, sheep, and swine may result in a local tissue reaction which persists beyond the withdrawal period of 14 days (cattle), 9 days (sheep), or 7 days (swine). This may result in trim loss of edible tissue at slaughter.

Allergic or anaphylactic reactions, sometimes fatal, have been known to occur in animals hypersensitive to penicillin and procaine. Such reactions can occur unpredictably with varying intensity. Animals administered penicillin G procaine should be kept under close observation for at least one half hour. Should allergic or anaphylactic reactions occur, discontinue use of the product and call a veterinarian. If respiratory distress is severe, immediate injection of epinephrine or antihistamine following manufacturer's recommendations may be necessary.

As with all antibiotic preparations, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi. A lack of response by the treated animal, or the development of new signs or symptoms suggest that an overgrowth of nonsusceptible organisms has occurred. In such instances, consult your veterinarian.

It is advisable to avoid giving penicillin in conjunction with bacteriostatic drugs such as tetracyclines.

Storage Conditions:

Norocillin should be stored between 2 to 8°C (36 to 46°F).

Restricted Drug - California. Use Only as Directed.

Made in the UK.

Norbrook Laboratories Limited

Newry, BT35 6PU, Co. Down, Northern Ireland

011670I01

Norbrook®

Principal Display Panel – 500 mL Vial Label

Norocillin

STERILE PENICILLIN G PROCAINE INJECTABLE SUSPENSION U.S.P.

NDC 55529-021-05

INJECTABLE ANTIBIOTIC IN AQUEOUS SUSPENSION 300,000 UNITS PER mL

ANTIBIOTIC

FOR INTRAMUSCULAR INJECTION ONLY

NADA 065-010, APPROVED BY FDA

Net Contents: 500 mL

Norbrook®

Norocillin  penicillin g procaine  injection, suspension

Product Information Product Type OTC ANIMAL DRUG NDC Product Code (Source) 55529-021 Route of Administration INTRAMUSCULAR DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength penicillin G procaine (penicillin G procaine) penicillin G procaine 300000 [USP'U]  in 1 mL

Inactive Ingredients Ingredient Name Strength penicillin G potassium   procaine hydrochloride   potassium phosphate, monobasic   potassium phosphate, dibasic   sodium formaldehyde sulfoxylate   polysorbate 80   methylparaben   water   carboxymethylcellulose sodium   lecithin, soybean

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 55529-021-02 100 mL In 1 VIAL, GLASS None 2 55529-021-04 250 mL In 1 VIAL, GLASS None 3 55529-021-05 500 mL In 1 VIAL, GLASS None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NADA	NADA065010	10/01/2008

Labeler - Norbrook Laboratories Limited (214580029)

Establishment
Name	Address	ID/FEI	Operations
Station Works		214580029	MANUFACTURE, ANALYSIS

Establishment
Name	Address	ID/FEI	Operations
Carnbane Industrial Estate		211218325	MANUFACTURE

Revised: 12/2010Norbrook Laboratories Limited

Chromagen

Pronunciation: EYE-urn/sux-IN-ic AS-id/VYE-ta-min C/VYE-ta-min B 12/DES-ih-kay-ted STUH-mak SUB-stans
Generic Name: Iron/Succinic Acid/Vitamin C/Vitamin B12/Desiccated Stomach Substance
Brand Name: Examples include Anemagen and Chromagen

Accidental overdose of products that contain iron is a leading cause of fatal poisoning in children younger than 6 years old. Keep this and all medicines out of the reach of children. In case of accidental ingestion, call the poison control center or a doctor at once.

Chromagen is used for:

Treating certain types of anemia that can be helped by increasing the amount of iron in the body (eg, anemia caused by pregnancy, blood loss, low dietary iron, metabolic disease, surgery). It may also be used for other conditions as determined by your doctor.

Chromagen is a combination of vitamins and minerals. It works by replacing iron in the body.

Do NOT use Chromagen if:

• you are allergic to any ingredient in Chromagen


• you have too much iron in your body (eg, hemochromatosis, hemosiderosis)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Chromagen:

Some medical conditions may interact with Chromagen. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have another type of anemia (eg, hemolytic anemia, megaloblastic anemia, pernicious anemia)


• if you have stomach or bowel problems (eg, Crohn disease, inflammation, ulcer), metabolism problems, porphyria, or a blood disease (eg, thalassemia)


• if you have had multiple blood transfusions

Some MEDICINES MAY INTERACT with Chromagen. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Doxycycline, penicillamine, or thyroid hormones (eg, levothyroxine) because their effectiveness may be decreased by Chromagen

This may not be a complete list of all interactions that may occur. Ask your health care provider if Chromagen may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Chromagen:

Use Chromagen as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Chromagen by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Swallow Chromagen whole. Do not break, crush, or chew before swallowing.


• Take Chromagen with a full glass of water (8 oz/240 mL). Do not lie down for 30 minutes after taking Chromagen.


• If you also take antacids, bisphosphonates (eg, etidronate), cephalosporins (eg, cefdinir), doxycycline, hydantoins (eg, phenytoin), levodopa, methyldopa, penicillamine, quinolones (eg, ciprofloxacin, levofloxacin), tetracyclines (eg, minocycline), or thyroid hormones (eg, levothyroxine), ask your doctor or pharmacist how to take them with Chromagen.


• If you miss a dose of Chromagen, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Chromagen.

Important safety information:

• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Do not take large doses of vitamins while you take Chromagen unless your doctor tells you to.


• Chromagen may cause your stools to darken. This is normal and not a cause for concern.


• Chromagen may interfere with certain lab tests, such as tests used to check for blood in the stool. Make sure your doctor and lab personnel know you are using Chromagen.


• Lab tests, including blood counts and iron levels, may be performed while you use Chromagen. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Chromagen should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Chromagen while you are pregnant. Chromagen is found in breast milk. If you are or will be breast-feeding while you use Chromagen, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Chromagen:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; darkened or green stools; diarrhea; nausea; stomach upset; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; blood or streaks of blood in the stool; severe or persistent vomiting or stomach pain.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Chromagen side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include black, tarry stools; chest pain; coma; dizziness; fast heartbeat; fever; increased or decreased urination; increased thirst or hunger; seizures; severe nausea, vomiting, diarrhea, or stomach pain; shortness of breath; sluggishness; trouble breathing; unusual tiredness or drowsiness; unusually pale skin; weak pulse.

Proper storage of Chromagen:

Store Chromagen at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Chromagen out of the reach of children and away from pets.

General information:

• If you have any questions about Chromagen, please talk with your doctor, pharmacist, or other health care provider.


• Chromagen is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Chromagen. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Chromagen resources

• Chromagen Side Effects (in more detail)
• Chromagen Use in Pregnancy & Breastfeeding
• Drug Images
• Chromagen Drug Interactions
• Chromagen Support Group
• 0 Reviews for Chromagen - Add your own review/rating

• multivitamin with iron Concise Consumer Information (Cerner Multum)


• Allbee-C 800 with Iron Concise Consumer Information (Cerner Multum)


• Ferotrin Prescribing Information (FDA)


• Ferralet 90 Prescribing Information (FDA)


• Ferrex 150 Forte Prescribing Information (FDA)


• Ferrex 150 Forte Plus Prescribing Information (FDA)


• Ferrex 28 Prescribing Information (FDA)


• FerroGels Forte Prescribing Information (FDA)


• Hematogen Forte Prescribing Information (FDA)


• Integra F Prescribing Information (FDA)


• Integra Plus Prescribing Information (FDA)


• Irospan 24/6 Prescribing Information (FDA)


• NovaFerrum Prescribing Information (FDA)


• Tricon Prescribing Information (FDA)

Compare Chromagen with other medications

• Anemia
• Vitamin/Mineral Supplementation and Deficiency

Aureomycin 100 Granule

Dosage Form: FOR ANIMAL USE ONLY
Aureomycin®

100 Granular

Chlortetracycline

Type A Medicated Article

Active drug ingredient

Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb.

Ingredients

Dried Streptomyces aureofaciens Fermentation Product and Calcium Sulfate.

For use in the manufacture of medicated animal feeds.

For use in dry feed only. Not for use in liquid medicated feeds.

Use directions

Mix sufficient Aureomycin 100 Granular Medicated Article to supply desired concentration of chlortetracycline per ton with part of the feed ingredients to make a preblend. Add the remainder of the ingredients and mix thoroughly. For specific use levels, see Indications.

Mixing directions

Level desired grams per ton	Amount of medicated article per ton*
* It is recommended that 1 pound of Aureomycin 100 Granular Type A Medicated Article be diluted with 3 pounds of one of the feed ingredients to form a 4 pound working premix. Use 2 pounds of the working premix to make a preblend (see Use directions) for a Type C feed containing 50 g Aureomycin chlortetracycline / ton of feed.
50	1/2 lb
100	1 lb
200	2 lb
400	4 lb
500	5 lb

Indications	Chlortetracycline mg per lb body wt per day
Cattle
Calves (up to 250 lb): Increased rate of weight gain and improved feed efficiency.	0.1
Beef Cattle (over 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.	0.5
Beef and Non-Lactating Dairy Cattle: As an aid in control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline when delivered in a free-choice feed. Free-choice feed must be manufactured under a feed mill license utilizing an FDA approved formulation.	0.5-2.0
Calves, Beef and Non-Lactating Dairy Cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Feed for not more than 5 days. The appropriate amount of Aureomycin-containing feed supplement may be mixed in the cattle's daily ration or administered as a top-dress. If the Aureomycin-containing feed supplement is administered as a top-dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time.	10
Swine
Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: this drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight.) Feed for not more than 14 days.	10
Turkeys
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis; coronaviral enteritis) susceptible to chlortetracycline. Feed continuously for 7 to 14 days.	25
Indications	mg per head per day
Cattle
Calves (250 to 400 lb): Increased rate of weight gain and improved feed efficiency.	25-70
Growing Cattle (over 400 lb): Increased rate of weight gain, improved feed efficiency, and reduction of liver condemnation due to liver abscesses.	70
Beef Cattle: Control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.	350
Beef Cattle (under 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.	350
Sheep
Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline.	80
Indications	In complete feed Chlortetracycline g per ton
Swine
Increased rate of weight gain and improved feed efficiency.	10-50
Reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline.	50-100
Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. Feed continuously for not more than 14 days.	400
Sheep
Increased rate of weight gain and improved feed efficiency.	20-50
Ducks
Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline. Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending upon age and severity of disease. Feed for not more than 21 days.	200-400
Chickens
Increased rate of weight gain and improved feed efficiency.	10-50
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days.	100-200
Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline. Feed continuously for 7 to 14 days.	200-400
Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline. Feed for 5 days.	500
Turkeys
Increased rate of weight gain and improved feed efficiency.	10-50
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days.	200
Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline. Feed continuously for 7 to 14 days.	400
Turkey Poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline.	400
Indications	mg per g feed
Psittacine birds
Warning: Psittacosis, avian chlamydiosis, or ornithosis is a reportable communicable disease, transmissible between wild and domestic birds, other animals and man. Contact appropriate public health and regulatory officials.
Caution: Aspergilliosis may occur following prolonged treatment.
Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline. Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of its body weight daily. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.	10

Warning

A withdrawal period has not been established for this product in pre-ruminating calves.

Do not use in calves to be processed for veal.

Do not feed to ducks or turkeys producing eggs for human consumption.

NADA 48-761, Approved by FDA

Marketed by

Alpharma Inc.

Bridgewater, New Jersey 08807

Trademarks registered

by Alpharma Inc.

700388 0902

PRINCIPAL DISPLAY PANEL - 50 LB Bag

Aureomycin®

100 Granular

ALPHARMA

GUARANTEED

AUREOMYCIN®

CHLORTETRACYCLINE

Chlortetracycline

Type A Medicated Article

See mixing directions, claims, cautions

and warnings on back

Net wt 50 LB (22.68 kg)

Aureomycin®

100 Granular

PRINCIPAL DISPLAY PANEL - 2000 LB Supersack

Aureomycin®

100 Granular

Chlortetracycline

Type A Medicated Article

Aureomycin is a registered trademark of Alpharma Inc.

Net wt 2000 LB (907 kg)

AHL-543 0812

Lot No.:

Expiration Date:

AUREOMYCIN  chlortetracycline hydrochloride  granule

Product Information Product Type OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG NDC Product Code (Source) 46573-006 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Chlortetracycline Hydrochloride (Chlortetracycline) Chlortetracycline Hydrochloride 100 g  in 0.45 kg

Inactive Ingredients Ingredient Name Strength calcium sulfate

Product Characteristics Color GRAY (gray to brown) Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 46573-006-00 22.68 kg In 1 BAG None 2 46573-006-18 909.1 kg In 1 SUPERSACK None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NADA	NADA048761	01/01/2009

Labeler - Alpharma Inc. Animal Health (070954094)

Establishment
Name	Address	ID/FEI	Operations
Alpharma Inc. Animal Health		005300025	MANUFACTURE, ANALYSIS, RELABEL, REPACK

Revised: 05/2009Alpharma Inc. Animal Health

Molypen

Generic Name: ammonium molybdate (Intravenous route, Injection route)

a-MOE-nee-um moe-LIB-date

Commonly used brand name(s)

In the U.S.

• Molypen

Available Dosage Forms:

• Solution

Therapeutic Class: Parenteral Mineral-Trace Mineral

Uses For Molypen

The body needs molybdenum for normal growth and health. For patients who are unable to get enough molybdenum in their regular diet or who have a need for more molybdenum, molybdenum supplements may be necessary. They are generally taken by mouth in multivitamin/mineral products but some patients may have to receive them by injection. Molybdenum is part of certain enzymes that are important for several body functions.

A deficiency of molybdenum is rare. However, if the body does not get enough molybdenum, certain enzymes needed by the body are affected. This may lead to a build up of unwanted substances in some people.

Injectable molybdenum is administered only by or under the supervision of your health care professional.

Importance of Diet

For good health, it is important that you eat a balanced and varied diet. Follow carefully any diet program your health care professional may recommend. For your specific dietary vitamin and/or mineral needs, ask your health care professional for a list of appropriate foods. If you think that you are not getting enough vitamins and/or minerals in your diet, you may choose to take a dietary supplement.

The amount of molybdenum in foods depends on the soil in which the food is grown. Some soils have more molybdenum than others. Peas, beans, cereal products, leafy vegetables, and low-fat milk are good sources of molybdenum.

The daily amount of molybdenum needed is defined in several different ways.

• For U.S.—


• Recommended Dietary Allowances (RDAs) are the amount of vitamins and minerals needed to provide for adequate nutrition in most healthy persons. RDAs for a given nutrient may vary depending on a person's age, sex, and physical condition (e.g., pregnancy).


• Daily Values (DVs) are used on food and dietary supplement labels to indicate the percent of the recommended daily amount of each nutrient that a serving provides. DV replaces the previous designation of United States Recommended Daily Allowances (USRDAs).

• For Canada—


• Recommended Nutrient Intakes (RNIs) are used to determine the amounts of vitamins, minerals, and protein needed to provide adequate nutrition and lessen the risk of chronic disease.

Because a lack of molybdenum is rare, there is no RDA or RNI for it. The following daily intakes are thought to be plenty for most individuals:

• Infants and children—
  
  • Birth to 3 years of age: 15 to 50 micrograms (mcg).
  
  
  • 4 to 6 years of age: 30 to 75 mcg.
  
  
  • 7 to 10 years of age: 50 to 150 mcg.
  
  


• Adolescents and adults—75 to 250 mcg.

Before Using Molypen

If you are taking this dietary supplement without a prescription, carefully read and follow any precautions on the label. For this supplement, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Problems in children have not been reported with intake of normal daily recommended amounts.

Geriatric

Problems in older adults have not been reported with intake of normal daily recommended amounts.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this dietary supplement. Make sure you tell your doctor if you have any other medical problems, especially:

• Copper deficiency—Molybdenum may make this condition worse

• Kidney disease or


• Liver disease—These conditions may cause higher blood levels of molybdenum, which may increase the chance of unwanted effects

Proper Use of Molypen

Molybdenum is available orally only as part of a multivitamin/mineral product.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage form (as part of a multivitamin/mineral supplement):
  
  • To prevent deficiency, the amount taken by mouth is based on normal daily recommended intakes:
    
    • Adults and teenagers—75 to 250 micrograms (mcg) per day.
    
    
    • Children 7 to 10 years of age—50 to 150 mcg per day.
    
    
    • Children 4 to 6 years of age—30 to 75 mcg per day.
    
    
    • Children birth to 3 years of age—15 to 150 mcg per day.
    
    
  
  
  • To treat deficiency:
    
    • Adults, teenagers, and children—Treatment dose is determined by prescriber for each individual based on severity of deficiency.
    
    
  
  

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Do not refrigerate. Keep from freezing.

Store the dietary supplement in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Molypen

Large amounts of molybdenum may cause your body to lose copper. Your health care professional may recommend that you take a copper supplement while on molybdenum therapy.

Molypen Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Symptoms of overdose

Note: Reported rarely in individuals consuming foods grown in soil containing a high content of molybdenum.

• Joint pain


• side, lower back, or stomach pain


• swelling of feet or lower legs

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Molypen resources

• Molypen Support Group
• 0 Reviews for Molypen - Add your own review/rating

Compare Molypen with other medications

• Dietary Supplementation